Novavax (NVAX) Files for WHO Emergency Use Listing of its COVID-19 Vaccine
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Nasdaq ticks up as tech stocks steady; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 9.87 -0.12 (1.2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.99 | 52 Week High | $9.23 | |||
| Open | $9.84 | 52 Week Low | $1.16 | |||
| Day High | $9.93 | P/E | N/A | |||
| Day Low | $9.62 | EPS | $-0.30 | |||
| Volume | 2,196,042 | |||||
